**Author details**

Ahmed Shawky Elserafy\* and Tarek Abdelsalam Cardiology Department, Ain Shams University, Cairo, Egypt

\*Address all correspondence to: ahmedshawkyelserafy@med.asu.edu.eg

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**133**

*Contrast-Induced Nephropathy*

[1] McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. The American Journal of Medicine. 1997;**103**:368-375

[2] Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Medical

[3] McCullough PA, Adam A, Becker CR, Avidson C, Lameire N, Stacul F, et al.

Weekly. 2012;**142**:w13608

Epidemiology and prognostic implications of contrast-induced nephropathy. The American Journal of

[4] Costa N. Understanding contrast media. Journal of Infusion Nursing.

[5] Bettmann MA. Contrast mediuminduced nephropathy: Critical review of the existing clinical evidence. Nephrology, Dialysis, Transplantation.

[6] Maddox TG. Adverse reactions to contrast material: Recognition, prevention, and treatment. American Family Physician. 2002;**66**(7):1229-1234

[7] McCullough PA, Stacul F,

2006;**98**(6A):2-4

Davidson C, et al. Overview. Contrastinduced nephropathy: Clinical insights and practical guidance. A report from the CIN consensus working panel. The American Journal of Cardiology.

[8] Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: A systematic review. The American Journal of Medicine. 2012;**125**:66-78.11

[9] Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital

Cardiology. 2006;**98**:5-13

2004;**27**(5):302-312

2005;**20**(Suppl1):2-17

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.90457*

acquired renal insufficiency: A prospective study. The American Journal of Medicine. 1983;**74**:243-248

[10] Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, et al. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). American Journal of Cardiology. 2012;**109**:67-74

[11] Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. International Journal of

Cardiology. 2008;**126**:407-413

2012;**81**:2554-2561

2010;**23**:658-666

2009;**31**:181-188

[12] Kooiman J, Pasha SM, Zondag W, Sijpkens YW, van der Molen AJ, Huisman MV, et al. Meta-analysis: Serum creatinine changes following contrast enhanced CT imaging. European Journal of Radiology.

[13] Karlsberg RP, Dohad SY, Sheng R. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media. Journal of Nephrology.

[14] Chuang FR, Chen TC, Wang IK, Chuang CH, Chang HW, Ting-Yu Chiou T, et al. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: A prospective

controlled study. Renal Failure.
